Alembic Global Holding SA gets USFDA nod for pulmonary arterial hypertension treatment injection

Drug firm Alembic Pharmaceuticals on Friday said its arm, Alembic
Global Holding SA, has received approval from the US health regulator
for its generic Treprostinil injection used for the treatment of
pulmonary arterial hypertension.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-global-holding-sa-gets-usfda-nod-for-pulmonary-arterial-hypertension-treatment-injection/articleshow/80879959.cms

Comments

Popular posts from this blog

Sunday Worship Service

Teva Regulatory Affairs Associate Job Vacancy – Apply Online

Teva Regulatory Affairs Job Vacancy – Pharma Candidates Apply